Search

Author/Creator Sockel, K.

4. P747: LR-MDS IS CHARACTERIZED BY DIFFERENTIAL EXPRESSION OF INFLAMMASOME-RELATED GENES IN SPECIFIC CELL POPULATIONS. (23rd June 2022)

Authors:
Rolfs, C.; Schneider, M.; Trumpp, M.; Fischer, L.; Winter, S.; Uxa, S.; Menger, V.; Nenoff, K.; Kubasch, A. S.; Metzeler, K.; Sockel, K.; Thiede, C.; Hofbauer, L.; Brüderle, A.; Woo, J.; Cross, M.; Platzbecker, U.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
642
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. P752: TARGETING S100A9 IN THE MYELODYSPLASTIC INFLAMMATORY BONE MARROW MICROENVIRONMENT BY TASQUINIMOD IMPROVES THE SUPPORTIVE FUNCTION OF MESENCHYMAL STROMAL CELLS. (23rd June 2022)

Authors:
Wobus, M.; Balaian, E.; Lissner, M.; Towers, R.; Oelschlägel, U.; Wehner, R.; Chavakis, T.; Törngren, M.; Eriksson, H.; Bondesson, E.; Platzbecker, U.; Bornhäuser, M.; Sockel, K.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
647
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. S169: CLINICAL AND MOLECULAR MARKERS FOR PREDICTING RESPONSE TO ROMIPLOSTIM TREATMENT IN LOWER-RISK MYELODYSPLASTIC SYNDROMES. (23rd June 2022)

Authors:
Kubasch, A. S.; Giagounidis, A.; Metzgeroth, G.; Jonasova, A.; Herbst, R.; Diaz, J. M. T.; De Renzis, B.; Götze, K. S.; Huetter-Kroenke, M.-L.; Gourin, M.-P.; Slama, B.; Dimicoli-Salazar, S.; Cony-Makhoul, P.; Laribi, K.; Park, S.; Jersemann, K.; Schipp, D.; Metzeler, K. H.; Tiebel, O.; Sockel, K.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
70
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Topic: AS04-MDS Biology and Pathogenesis/AS04b-Clonal diversity & evolution: MUTATIONAL PROFILING OF CLONAL HEMATOPOIESIS, MDS AND SAML DEPICTS DIVERSITIES OF CLONAL PROGRESSION. (September 2021)

Authors:
Hartmann, L.; Hecker, J.; Rothenberg-Thurley, M.; Rivière, J.; Ksienzyk, B.; Buck, M.; Van Der Garde, M.; Fischer, L.; Winter, S.; Rauner, M.; Tsourdi, E.; Sockel, K.; Schneider, M.; Kubasch, A.S.; Nolde, M.; Hausmann, D.; Lützner, J.; Roth, A.; Bassermann, F.; Spiekermann, K.
Journal:
Leukemia research
Issue:
Volume 108(2021)Supplement
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment: COMPARISON OF PROGNOSTICATION BY IPSS-M, IPSS-R AND AIPSS-MDS IN THE CONTEXT OF LIMITED AVAILABILITY OF MOLECULAR DATA IN DAILY CLINICAL PRACTICE. (May 2023)

Authors:
Schulz, F.; Kellersmann, C.; Betz, B.; Hildebrandt, B.; Thol, F.; Heuser, M.; Ganster, C.; Beier, F.; Sockel, K.; Hofmann, W.-K.; Kuendgen, A.; Pfeilstoecker, M.; Gattermann, N.; Nachtkamp, K.; Haase, D.; Germing, U.
Journal:
Leukemia research
Issue:
Volume 128(2023)Supplement
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment: INTERMEDIATE RISK KARYOTYPE BY IPSS-R CAN BE SEPARATED INTO 5 PROGNOSTICALLY DISTINCT SUBGROUPS IN MDS PATIENTS. (May 2023)

Authors:
Nachtkamp, K.; Flatten, V.; Hildebrandt, B.; Kasprzak, A.; Schulz, F.; Strupp, C.; Haase, D.; Ganster, C.; Shirneshan, K.; Rittscher, K.; Götze, K.; Hofmann, W.-K.; Platzbecker, U.; Pfeilstöcker, M.; Valent, P.; Blum, S.; Lübbert, M.; Parmentier, S.; Beier, F.; Sockel, K.
Journal:
Leukemia research
Issue:
Volume 128(2023)Supplement
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗